Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis. 1987

P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
Istituto di Neurologia, Università, Bari.

The separate correlations among CSF and clinical parameters (mononuclear cell count, assay of intrathecal IgG synthesis, assessment of blood-brain barrier permselectivity to albumin and alpha 2-macroglobulin, detection of oligoclonal intrathecal IgG isoelectric spectro-type; age, disease duration, disability, number of bouts) were investigated by multiple linear regression in 100 multiple sclerosis patients subdivided according to the course and the phase of the disease. Results indicate that the complexity of the oligoclonal CSF IgG isoelectric spectrotype increases, but the overall amount of intrathecal IgG synthesis decreases with increasing number of bouts or disease duration in relapsing remitting and in progressive courses respectively. The CSF mononuclear pleocytosis was low in progressive forms, and it appeared to be linked to the intrathecal IgG synthesis changes. The IgG synthesis rate was proportional to CSF pleocytosis, but a negative correlation between pleocytosis and complexity of CSF IgG spectrotype was found. About 40% of patients had a blood-brain barrier damage. The increased permeability to albumin was related to the number of previous bouts, whereas the CSF pleocytosis seemed to be accompanied by a loss of barrier selectivity to large serum molecules. High CSF IgG index, high mononuclear cell count and low number of prominent oligoclonal CSF IgG fractions characterize the less active or short-lasting disease. Low CSF IgG index with numerous, faint, abnormal IgG CSF bands, low mononuclear cell number and increased barrier permeability to albumin are associated with long-lasting or steady progressive disease.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
January 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
May 1983, Zhonghua yi xue za zhi,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
January 1990, Clinical neurology and neurosurgery,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
February 1991, Brain : a journal of neurology,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
November 1963, The Medical clinics of North America,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
January 1985, Wiener medizinische Wochenschrift (1946),
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
April 2000, Acta neurologica Scandinavica,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
September 1989, Journal of neurology,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
March 2023, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
P Livrea, and I L Simone, and M Trojano, and L Pisicchio, and G Logroscino, and A Rosato
January 2006, Disease markers,
Copied contents to your clipboard!